As a direct target of miR-1272, ADAM9 plays an important role in the progression of various glioma cell lines, supporting other studies that have reported that ADAM9 acts as an oncogene and is associated with tumor progression and poorer clinical outcomes. Here, ADAM9 is linked to central nervous system cancer.